Fig. 3From: Higher CD19+CD25+ Bregs are independently associated with better graft function in renal transplant recipientsComparison of absolute and relative counts of CD19+ B cells (a and b) and CD19+ CD25+ Bregs (c and d) between the Basiliximab-group and the ATG-group in renal transplant recipients. No statistically significant difference could be demonstrated between the two groupsBack to article page